The European Medicines Agency's plans for sharing data from clinical trials

BMJ (Online)

Volumn 346, Issue 7907, 2013, Pages

  Groves, Trish ^a   Godlee, Fiona ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ZANAMIVIR;

ACCESS TO INFORMATION; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG INFORMATION; DRUG RESEARCH; EDITORIAL; EUROPE; EVIDENCE BASED MEDICINE; INFORMATION DISSEMINATION; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL SCHOOL; PATIENT ADVOCACY; PATIENT CARE; PATIENT INFORMATION; PLANNING; PRIORITY JOURNAL; PUBLICATION; UNITED STATES; DRUG APPROVAL; EUROPEAN UNION; HUMAN; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT;

CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; DRUG INDUSTRY; EUROPEAN UNION; HUMANS; INFORMATION DISSEMINATION;

EID: 84878336121     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f2961     Document Type: Editorial

References (17)

1. European Medicines Agency. European Medicines Agency receives interim decisions of the general court of the EU on access to clinical and non-clinical information. Press release 30 April 2013. www.ema.europa.eu/ema/index.jsp?curl= pages/news-and-events/news/2013/04/news-detail-001779.jsp&mid= WC0b01ac058004d5c1.
2. Kmietowicz Z. European regulator is ordered not to release clinical study documents. BMJ 2013;346:f2846.
3. European Medicines Agency. European Medicines Agency sets out next steps on access to clinical trial data. Press release 5 December 2012. www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2012/12/ news-detail-001669.jsp&mid=WC0b01ac058004d5c1.
4. McGauran N, Wieseler B, Kreis J, Schüler YB, Kölsch H, Kaiser T. Reporting bias in medical research-a narrative review. Trials 2010;11:37.
5. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet 2009;374:86-9.
6. Lomas A. I'm a patient: show me the trial data. BMJ 2013;346:f2336.
7. Yale School of Medicine Yale University Open Data Access (YODA) Project. http://medicine.yale.edu/core/projects/yodap/index.aspx.
8. GlaxoSmithKline. GSK announces support for AllTrials campaign for clinical data transparency. Press release 5 Feb 2013. www.gsk.com/media/press- releases/2013/GSKannounces-support-forAll-Trials-campaign-for-clinical-data- transparency.html.
9. Kmietowicz Z. GSK backs campaign for disclosure of trial data. BMJ 2013;346:f819.
10. Groves T. Data sharing: where are we? BMJ 7 May 2013. http://blogs.bmj.com/bmj/2013/05/07/trish-groves-data-sharing-where-are-we/.
11. AllTrials. All trials registered: all results reported. http://alltrials.net.
12. Institute of Medicine. IOM plans to develop consensus study on strategies for sharing clinical trial data. www.iom.edu/Activities/Research/ SharingClinicalResearchData/Planned-Consensus-Study.aspx.
13. House of Commons Science and Technology Committee. Clinical trials. Written evidence. 6 March 2013. www.parliament.uk/documents/commons-committees/ science-technology/Clinical%20trials%20combined.pdf.
14. Murray J. Clinical trials directive: the Parliament's political dilemma. 2013. www.euractiv.com/health/european-parliament-clinical-tri-analysis-518898.
15. Godlee F, Groves T. The new BMJ policy on sharing data from drug and device trials. BMJ 2012;345:e7888.
16. EMA. Documents from advisory groups on clinical trial data. 2013. www.ema.europa.eu/ema/index.jsp?curl=pages/special-topics/document-listing/ document-listing-000368.jsp&mid=WC0b01ac058067d984.
17. European Medicines Agency. European Medicines Agency reorganisation. Press release 3 May 2013. www.ema.europa.eu/ema/index.jsp?curl=pages/news-and- events/news/2013/05/news-detail-001781.jsp&mid=WC0b01ac058004d5c1.